Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2022

Financial Instruments, Owned, at Fair Value, by Type, Alternative [Abstract]

Schedule of available-for-Sale financial instruments

The following is a summary of available-for-sale financial instruments, as of September 30, 2022 and December 31, 2021 (in thousands):

	September 30, 2022
	Amortized Cost		Unrealized Gain		Unrealized Losses			Fair Value
Cash equivalents:
U.S. treasury and agency securities	$	2,392	$	6	$	-			2,398
Total cash equivalents		2,392		6		-			2,398
Marketable securities:
Corporate securities (1)		152,492		-		(2,617	)		149,875
U.S. treasury and agency securities		57,999		-		(313	)		57,686
Total marketable securities		210,491	$	-	$	(2,930	)		207,561
(1) Comprised primarily of corporate bonds and commercial paper

	December 31, 2021
	Amortized Cost		Unrealized Gain		Unrealized Losses			Fair Value
Corporate securities	$	7,709	$	-	$	(1	)	$	7,708
U.S. treasury and agency securities		6,060		-		(3	)		6,057
Total marketable securities	$	13,769	$	-	$	(4	)	$	13,765

Schedule of fair values of available-for-sale financial instruments

As of September 30, 2022, the fair values of available-for-sale financial instruments, by remaining contractual maturity, were as follows (in thousands):

Due within one year	$	133,289
Due in one to five years		76,670
Total	$	209,959